Array Technologies Inc. (ARRY) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Array Technologies Inc. (ARRY) Announces $500 Million Capital Commitment from Blackstone (BX)
August 11, 2021 4:02 PM EDTArray Technologies, Inc. (Nasdaq: ARRY), one of the worlds largest manufacturers of utility-scale solar technology, today announced that it had entered into an agreement to sell up to $500 million of perpetual preferred stock to private equity funds managed by Blackstone Energy Partners (Blackstone). Under the terms of the agreement, Array will sell $350 million of perpetual preferred stock to Blackstone at the initial closing and, at the Companys option, up to an additional $150 million of perpetual preferred stock at any time prior to June 30, 2023. The perpetual preferred stock will be entitled to cash... More
Pre-Open Stock Movers 08/10: (ZEV) (ARCT) (FSR) Higher; (MILE) (SDCX) (RETA) Lower (more...)
August 10, 2021 9:25 AM EDTPre-Open Stock Movers:
Lightning eMotors (NYSE: ZEV) 59% HIGHER; Lightning eMotors and Forest River, Inc., a Berkshire Hathaway company (NYSE: BRK.A), today announced they have entered into a strategic partnership agreement to deploy up to 7,500 zero-emission shuttle buses.
Arcturus Therapeutics (NASDAQ: ARCT) 36% HIGHER; ARCT-021, Arcturus single shot STARR mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study funded and sponsored by a global entity; ARCT-154, Arcturus STARR mRNA vaccine candidate targeting COVID variants of concern, elicits robust... More
UPDATE: Roth Capital Upgrades Array Technologies (ARRY) to Buy
August 10, 2021 4:30 AM EDT(Updated - August 10, 2021 5:28 AM EDT)
Roth Capital analyst Philip Shen upgraded Array Technologies (NASDAQ: ARRY) from Neutral to Buy with a price target of $25.00.
The analyst comments "Heading into Q2, we are incrementally more bullish on ARRY. With the... More

